ABL1 and neoplasm: In addition, by inhibiting myristoylation of important proto-oncogenes like c-Src, c-Abl, or others, the NMT inhibitors display potent anti-tumor activity and have produced complete anti-tumor responses in preclinical murine models [23,24,25,26,27].